BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17218236)

  • 1. NovaSure impedance controlled endometrial ablation: long-term follow-up results.
    Fulop T; Rákóczi I; Barna I
    J Minim Invasive Gynecol; 2007; 14(1):85-90. PubMed ID: 17218236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients.
    Gallinat A
    J Reprod Med; 2007 Jun; 52(6):467-72. PubMed ID: 17694962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients.
    Gallinat A
    Am J Obstet Gynecol; 2004 Nov; 191(5):1585-9. PubMed ID: 15547528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study.
    Sabbah R; Desaulniers G
    J Minim Invasive Gynecol; 2006; 13(5):467-71. PubMed ID: 16962534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Office endometrial ablation with local anesthesia using the HydroThermAblator system: Comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5(1/2) years.
    Glasser MH; Heinlein PK; Hung YY
    J Minim Invasive Gynecol; 2009; 16(6):700-7. PubMed ID: 19896596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
    Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
    J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation.
    Kleijn JH; Engels R; Bourdrez P; Mol BW; Bongers MY
    BJOG; 2008 Jan; 115(2):193-8. PubMed ID: 17617188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial ablation with NovaSure GEA, a pilot study.
    Busund B; Erno LE; Grønmark A; Istre O
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):65-8. PubMed ID: 12580843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding.
    Hawe J; Abbott J; Hunter D; Phillips G; Garry R
    BJOG; 2003 Apr; 110(4):350-7. PubMed ID: 12699795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cavaterm thermal balloon endometrial ablation versus hysteroscopic endometrial resection to treat menorrhagia: the French, multicenter, randomized study.
    Brun JL; Raynal J; Burlet G; Galand B; Quéreux C; Bernard P
    J Minim Invasive Gynecol; 2006; 13(5):424-30. PubMed ID: 16962526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypectomy in premenopausal women with abnormal uterine bleeding: effectiveness of hysteroscopic removal.
    Henriquez DD; van Dongen H; Wolterbeek R; Jansen FW
    J Minim Invasive Gynecol; 2007; 14(1):59-63. PubMed ID: 17218231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miscellaneous uterine malignant neoplasms detected during hysteroscopic surgery.
    Vilos GA; Edris F; Abu-Rafea B; Hollett-Caines J; Ettler HC; Al-Mubarak A
    J Minim Invasive Gynecol; 2009; 16(3):318-25. PubMed ID: 19423062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial hydrothermablation: a comparison of short-term clinical effectiveness in patients with normal endometrial cavities and those with intracavitary pathology.
    Rosenbaum SP; Fried M; Munro MG
    J Minim Invasive Gynecol; 2005; 12(2):144-9. PubMed ID: 15904618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term follow-up after endometrial ablation. A questionnaire study on bleedings, hormone treatment and surgery].
    Krogh RA; Lauszus FF; Rasmussen KL
    Ugeskr Laeger; 2009 Aug; 171(34):2371-6. PubMed ID: 19732517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
    Gunes M; Ozdegirmenci O; Kayikcioglu F; Haberal A; Kaplan M
    J Minim Invasive Gynecol; 2008; 15(6):735-8. PubMed ID: 18971138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation endometrial ablation treatment: Novasure.
    Bongers MY
    Best Pract Res Clin Obstet Gynaecol; 2007 Dec; 21(6):989-94. PubMed ID: 17490913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving results of hysteroscopic submucosal myomectomy for menorrhagia by concomitant endometrial ablation.
    Loffer FD
    J Minim Invasive Gynecol; 2005; 12(3):254-60. PubMed ID: 15922984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term effect on radiofrequency heat-coagulation endometrial ablation in the treatment of anovulatory dysfunctional uterine bleeding].
    Yin GP; Li J; Zhu TY; Chen M; Yang SJ; Zhao XL
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):664-8. PubMed ID: 22176990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy.
    Vilos GA; Tureanu V; Garcia M; Abu-Rafea B
    J Minim Invasive Gynecol; 2009; 16(4):480-4. PubMed ID: 19573825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year follow-up of endometrial ablation.
    Fürst SN; Philipsen T; Joergensen JC
    Acta Obstet Gynecol Scand; 2007; 86(3):334-8. PubMed ID: 17364309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.